ImmunoTherapyNews.net

Cancer immunotherapy

Xagena Mappa
Medical Meeting
Ematobase.it
XagenaNewsletter

Search results for "Renal cell carcinoma"

Nivolumab ( Opdivo ) is a fully human immunoglobulin G4 programmed death-1 immune checkpoint inhibitor antibody that restores T-cell immune activity. This phase II trial assessed the antitumor activ ...